PMID: 9532632Apr 9, 1998Paper

Utility of the nasal model in gene transfer studies in cystic fibrosis

Rhinology
S M Graham, J L Launspach

Abstract

Despite advances in the treatment for cystic fibrosis (CF), life expectancy for affected patients remains dramatically curtailed. Recent years have produced a spectacular increase in our understanding of the genetic, molecular and physiological bases of this disease. Gene transfer is a new and conceptually-attractive potential treatment for CF. A number of centres have undertaken preliminary human gene-therapy trials. Central to these trials has been the use of the nasal model in gene transfer studies. While the eventual target of gene therapy in CF will be the lungs, the nasal administration of vector offers a number of advantages over the tracheobronchial tree in early experimentation. Implicit in the use of the nasal model is the potential for rhinologic variables to influence the results. We review our own gene transfer studies as well as series from other institutions, considering the role of nasal factors in the experiments' outcomes. Rhinologic variables may, at least partially, potentially explain the sometimes disparate results reported in this emerging area of scientific interest.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
A FreeseM J During
Molecular Medicine Today
D A Treco, R F Selden
Nature Reviews. Genetics
Jochen GrawRainer Schwaab
Nature Reviews. Immunology
Charlotte Cunningham-Rundles, Prashant P Ponda
© 2022 Meta ULC. All rights reserved